GeneSilico is an AI-powered precision oncology company that combines genomic data and real-world evidence to help oncologists deliver personalized cancer care at scale. Our conversational AI combines global expertise, peer insights, and the latest research to support optimal treatment decisions at the point of care, making us a trusted partner for oncologists navigating complex cases. We believe in oncologists and aim to be their best partner.
| Website | https://genesilico.ai/ |
| Employees | 37 (21 on RocketReach) |
| Founded | 2024 |
| Industry | Software Development |
| Keywords | Precision Oncology, Oncology Ai, Personalized Cancer Care, Artificial Intelligence, Cancer Care, Personalized Medicine, Genomic Data Analysis, Cancer Treatment, Machine Learning Oncology, Clinical Decision Support, Digital Oncology, Ai Powered Healthcare, Cancer Research, Data Driven Oncology, Healthcare Ai, Real World Evidence, Genomics, Conversational Ai |
| Competitors | Elekta, Recursion Pharmaceuticals, Twist Bioscience, SOPHiA GENETICS, Insilico Medicine, BenchSci, Geno, Atomwise, BioSymetrics, CureMetrix +33 more (view full list) |
Looking for a particular GeneSilico employee's phone or email?
Tammy Shvartsman is the Chief Product Officer of GeneSilico.
21 people are employed at GeneSilico.